138 related articles for article (PubMed ID: 26393496)
21. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital.
Souli M; Kontopidou FV; Papadomichelakis E; Galani I; Armaganidis A; Giamarellou H
Clin Infect Dis; 2008 Mar; 46(6):847-54. PubMed ID: 18269335
[TBL] [Abstract][Full Text] [Related]
22. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia.
Reddy P; Malczynski M; Obias A; Reiner S; Jin N; Huang J; Noskin GA; Zembower T
Clin Infect Dis; 2007 Oct; 45(7):846-52. PubMed ID: 17806048
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae blood isolates with inducible AmpC β-lactamase.
Cheong HS; Ko KS; Kang CI; Chung DR; Peck KR; Song JH
Microb Drug Resist; 2012 Aug; 18(4):446-52. PubMed ID: 22409779
[TBL] [Abstract][Full Text] [Related]
24. Enterobacteriaceae Sepsis Outcome Programme annual report, 2013.
Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Daly DA; Bell JM;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E327-33. PubMed ID: 25631595
[TBL] [Abstract][Full Text] [Related]
25. Treatment of KPC-producing Enterobacteriaceae: suboptimal efficacy of polymyxins.
de Oliveira MS; de Assis DB; Freire MP; Boas do Prado GV; Machado AS; Abdala E; Pierrotti LC; Mangini C; Campos L; Caiaffa Filho HH; Levin AS
Clin Microbiol Infect; 2015 Feb; 21(2):179.e1-7. PubMed ID: 25599940
[TBL] [Abstract][Full Text] [Related]
26. Incidence rates of carbapenemase-producing Enterobacteriaceae clinical isolates in France: a prospective nationwide study in 2011-12.
Robert J; Pantel A; Mérens A; Lavigne JP; Nicolas-Chanoine MH;
J Antimicrob Chemother; 2014 Oct; 69(10):2706-12. PubMed ID: 24942333
[TBL] [Abstract][Full Text] [Related]
27. Childhood cancer in Italy: background, goals, and achievements of the Italian Paediatric Hematology Oncology Association (AIEOP).
Zecca M; Ferrari A; Quarello P; Rabusin M; Balduzzi A; Buldini B; Rostagno E; Prete A; Favre C; Massimino M; Biondi A; Porta F; Biffi A; Locatelli F; Pession A; Fagioli F
Tumori; 2021 Oct; 107(5):370-375. PubMed ID: 33876662
[TBL] [Abstract][Full Text] [Related]
28. [Community- and non-community-acquired bacteremia: correlation between empiric antimicrobial therapy and susceptibility of micro-organisms isolated during 2007 in the Ile-de-France microbiologists network].
Porcheret H; Barraud D; Bingen M; Rabenja T; Costa Y; Estève V; Faibis F; Demachy MC; Scanvic A; Vallée E; Péan Y
Pathol Biol (Paris); 2010 Apr; 58(2):e7-e14. PubMed ID: 19875246
[TBL] [Abstract][Full Text] [Related]
29. Factors influencing antimicrobial resistance and outcome of Gram-negative bloodstream infections in children.
Ivády B; Kenesei É; Tóth-Heyn P; Kertész G; Tárkányi K; Kassa C; Ujhelyi E; Mikos B; Sápi E; Varga-Heier K; Guóth G; Szabó D
Infection; 2016 Jun; 44(3):309-21. PubMed ID: 26546372
[TBL] [Abstract][Full Text] [Related]
30. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
[TBL] [Abstract][Full Text] [Related]
31. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies.
Vehreschild MJ; Hamprecht A; Peterson L; Schubert S; Häntschel M; Peter S; Schafhausen P; Rohde H; Lilienfeld-Toal MV; Bekeredjian-Ding I; Libam J; Hellmich M; Vehreschild JJ; Cornely OA; Seifert H
J Antimicrob Chemother; 2014 Dec; 69(12):3387-92. PubMed ID: 25103492
[TBL] [Abstract][Full Text] [Related]
32. [Bacteraemia due to extended-spectrum beta-lactamases (ESBL) and other beta-lactamases (ampC and carbapenemase) producing Enterobacteriaceae: association with health-care and cancer].
García-Gómez M; Guío L; Hernández JL; Vilar B; Pijoán JI; Montejo JM
Rev Esp Quimioter; 2015 Oct; 28(5):256-62. PubMed ID: 26437756
[TBL] [Abstract][Full Text] [Related]
33. Carbapenem non-susceptible enterobacteriaceae in Quebec, Canada: results of a laboratory surveillance program (2010-2012).
Lefebvre B; Lévesque S; Bourgault AM; Mulvey MR; Mataseje L; Boyd D; Doualla-Bell F; Tremblay C
PLoS One; 2015; 10(4):e0125076. PubMed ID: 25910041
[TBL] [Abstract][Full Text] [Related]
34. Colonization of high-risk children with carbapenemase-producing Enterobacteriaceae in Greece.
Mougkou K; Michos A; Spyridopoulou K; Daikos GL; Spyridis N; Syriopoulou V; Zaoutis T
Infect Control Hosp Epidemiol; 2013 Jul; 34(7):757-9. PubMed ID: 23739084
[No Abstract] [Full Text] [Related]
35. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
Netikul T; Kiratisin P
PLoS One; 2015; 10(9):e0139116. PubMed ID: 26407326
[TBL] [Abstract][Full Text] [Related]
36. Enterobacteriaceae bacteremia: risk factors for ESBLPE.
Neulier C; Birgand G; Ruppé É; Armand-Lefèvre L; Lolom I; Yazdanpanah Y; Lucet JC; Andremont A
Med Mal Infect; 2014 Jan; 44(1):32-8. PubMed ID: 24321202
[TBL] [Abstract][Full Text] [Related]
37. Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections.
Trecarichi EM; Cauda R; Tumbarello M
Future Microbiol; 2012 Oct; 7(10):1173-89. PubMed ID: 23030423
[TBL] [Abstract][Full Text] [Related]
38. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital.
Zhao ZC; Xu XH; Liu MB; Wu J; Lin J; Li B
Am J Infect Control; 2014 May; 42(5):e61-4. PubMed ID: 24773806
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain.
Palacios-Baena ZR; Oteo J; Conejo C; Larrosa MN; Bou G; Fernández-Martínez M; González-López JJ; Pintado V; Martínez-Martínez L; Merino M; Pomar V; Mora-Rillo M; Rivera MA; Oliver A; Ruiz-Carrascoso G; Ruiz-Garbajosa P; Zamorano L; Bautista V; Ortega A; Morales I; Pascual Á; Campos J; Rodríguez-Baño J;
J Infect; 2016 Feb; 72(2):152-60. PubMed ID: 26546855
[TBL] [Abstract][Full Text] [Related]
40. Persistence of TEM-52/TEM-92 and SHV-12 extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae in Italy.
Perilli M; Segatore B; Mugnaioli C; Celenza G; Rossolini GM; Stefani S; Luzzaro F; Pini B; Amicosante G
Microb Drug Resist; 2011 Dec; 17(4):521-4. PubMed ID: 21970626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
